Costco has announced that it will not sell the abortion pill mifepristone at its pharmacies across the United States. This decision has received praise from pro-life advocates. Costco joins other large retailers, including Walmart and Kroger, in refusing to offer this controversial medication, which has faced scrutiny regarding its safety for women.
In a statement, Costco explained that its choice not to sell mifepristone stems from low demand among its members and patients, who typically get the drug through their healthcare providers. The announcement has been seen as a significant victory by some pro-life organizations. Jeremy Tedesco, a legal expert from Alliance Defending Freedom, called it a “huge win,” emphasizing that Costco’s decision was based on business considerations rather than pressure from activists.
Pro-life supporters have been quick to commend Costco’s stance, urging other pharmacies, like CVS and Walgreens, to follow suit. Activist Lila Rose criticized these companies for selling mifepristone, calling on them to stop what she described as “trafficking in the deaths of children.” Kristan Hawkins from Students for Life echoed this sentiment, celebrating Costco’s decision as a commitment to protecting both mothers and unborn babies.
The safety of mifepristone is a central issue in the ongoing debate over abortion. The drug is used to terminate early pregnancies, often in combination with another medication, misoprostol. However, there are concerns that it may not always work effectively, leading to serious health risks for women. Recent studies have shown that more than 10% of women experienced severe complications after taking mifepristone, a figure significantly higher than what the FDA had previously reported.
In light of these concerns, FDA Commissioner Marty Makary has pledged to review the safety data on mifepristone. This review aims to ensure that the drug’s risks are properly understood and communicated.
As the conversation around abortion and medication continues, Costco’s decision highlights the complexities retailers face in balancing public demand, safety concerns, and corporate values.
